Neuroprotection: A new therapeutic option in the treatment of Epilepsy?;Neuroprotektion: Eine neue therapeutische option in der epilepsietherapie?

Aktuelle Neurologie

Volumn 28, Issue 7, 2001, Pages 326-332

  Schurks M ^a   Wiegand, F ^b   Diener, H C ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b JANSSEN CILAG GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM; CARBAMAZEPINE; ETIRACETAM; FELBAMATE; GABAPENTIN; IONOTROPIC RECEPTOR; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; SODIUM; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

CALCIUM TRANSPORT; COGNITIVE DEFECT; DISEASE COURSE; DRUG EFFECT; EPILEPSY; EPILEPTIC STATE; GABAERGIC SYSTEM; HUMAN; NERVE CELL LESION; NEUROPROTECTION; PATHOPHYSIOLOGY; REVIEW; SODIUM TRANSPORT;

EID: 0034843394     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-16869     Document Type: Review

References (60)

1. Epileptic seizures in an Andean region of Ecuador: Incidence and prevalence and regional variation
2. Prevalence of the epilepsies in Nigerian africans: A community based study
3. Topiramate reduces neuronal injury after experimental status epilepticus
4. Hemicranial volume deficits in patients with temporal lobe epilepsy with and without hippocampal sclerosis
5. Does antiepileptic drug therapy prevent the development of chronic epilepsy?
6. Is epilepsy a progressive disease? The neurobiological consequences of epilepsy
7. Mossy fiber synaptic reorganization induced by kindling: Time course of development, progression, and performance
8. Valproate for preventing late posttraumatic seizures
9. Pharmacological prophylaxis in the kindling model of epilepsy
10. Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy
11. Conditions for pharmacological evaluation in the gerbil model of forebrain ischemia
12. Phenytoin protects against ischemia-produced neuronal cell death
13. Phenytoin affects metabolism of fatty free acids and nucleotides in rat cerebral ischemia
14. +-ATPase activity in global ischemic rat brain
15. Fosphenytoin reduces hippocampal neuronal damage in rat following transient global ischemia
16. Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in rat
17. Phenytoin reduces neonatal hypoxic-ischemic brain damage in rats
18. Phenytoin pretreatment prevents hypoxic-ischemic brain damage in neonatal rats
19. Prophylactic effects of phenytoin, phenobarbital and carbamazepine examined in kindling cat preparations
20. Carbamazepine and carbamazepine-10,11-epoxide inhibit amygdala-kindled seizures in the rat but do not block their development
21. Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum
22. Long-term neuroprotection by benzodiazepine full versus partial agonists after transient cerebral ischemia in the gerbil
23. Benzodiazepines protect hippocampal neurons from degeneration after transient cerebral ischemia: An ultrastructural study
24. Diazepam-induced neuroprotection: Dissociating the effects of hypothermia following global ischemia
25. Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy
26. Cerebroprotective effect of lamotrigine after focal ischemia in rats
27. Lamotrigine improves cerebral outcome after hypothermic circulatory arrest: A study in a chronic porcine model
28. Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest
29. Neuroprotective effect of lamotrigine in global ischemia in gerbils. A histological, in vivo microdialysis and behavioral study
30. Moclobemide reduces intracellular pH and neuronal activity of CA3 neurones in guinea-pig hippocampal slices - Implication for its neuroprotective properties
31. An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action
32. Topiramate: A potent anticonvulsant in the amygdala-kindled rat
33. Anticonvulsant efficacy of topiramate in phenytoin-resistant kindled rats
34. Topiramate as add-on therapy: Pooled analysis of randomized controlled trials in adults
35. Topiramate in the long-term management of refractory epilepsy
36. Antiepileptic effects of topiramate on amygdaloid kindling in rats
37. Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbil
38. Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolisation
39. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia
40. Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate
41. Ucb L059, a novel anti-convulsant drug: Pharmacological profile in animals
42. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy
43. Development of tolerance during chronic treatment of kindled rats with the novel antiepileptic drug levetiracetam
44. Neuroprotective effects of levetiracetam
45. Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy
46. Tiagabine exerts an antiepileptogenic effect in amygdala kindling epileptogenesis in the rat
47. Neuroprotective activity of tiagabine in a focal embolic model of cerebral ischemia
48. Dose-dependent neuroprotection with tiagabine in a focal cerebral ischemia model in rat
49. Postischemic inhibition of GABA reuptake by tiagabine slows neuronal death in the gerbil hippocampus
50. Anticonvulsant efficacy of gabapentin and levetiracetam in phenytoin-resistant kindled rats
51. Antimyoclonic effect of gabapentin in a posthypoxic animal model of myoclonus
52. Gabapentin-lactam (8-azaspiro(5,4)decan-9-on; GBP-L) inhibits oxygen glucose deprivation-induced (3H)glutamate release and is a neuroprotective agent in a model of acute retinal ischemia
53. Glycine reversal of felbamate hypoxic protection
54. Excitoprotective effect of felbamate in cultured cortical neurons
55. Posthypoxic treatment with felbamate is neuroprotective in a rat model of hypoxia-ischemia
56. Felbamate protects CA1 neurons from apoptosis in a gerbil model of global ischemia
57. Neuroprotection with felbamate: A 7- and 28-day study in transient forebrain ischemia in gerbils
58. Proton magnetic resonance spectroscopic imaging studies in patients with newly diagnosed partial epilepsy
59. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures
60. Valproate for preventing late posttraumatic seizures